Clinical Biomarker of Sterile Inflammation, HMGB1, in Patients with Chronic Non-Specific Low Back Pain: A Pilot Cross-Sectional Study

The present study explores whether the inflammatory biomarker of sterile inflammation, high mobility box 1 (HMGB1), contributes to the inflammatory/nociceptive pathophysiology that characterizes chronic non-specific low back pain (LBP). Patients with chronic LBP (N = 10, >3 pain score on a 11-poi...

Full description

Bibliographic Details
Main Authors: Julita A. Teodorczyk-Injeyan, Heba Khella, H. Stephen Injeyan
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/13/2/468
_version_ 1797619857900961792
author Julita A. Teodorczyk-Injeyan
Heba Khella
H. Stephen Injeyan
author_facet Julita A. Teodorczyk-Injeyan
Heba Khella
H. Stephen Injeyan
author_sort Julita A. Teodorczyk-Injeyan
collection DOAJ
description The present study explores whether the inflammatory biomarker of sterile inflammation, high mobility box 1 (HMGB1), contributes to the inflammatory/nociceptive pathophysiology that characterizes chronic non-specific low back pain (LBP). Patients with chronic LBP (N = 10, >3 pain score on a 11-point Visual Analogue Scale, VAS) and asymptomatic participants (N = 12) provided peripheral blood (PB) samples. The proportion of classical CD14++ monocytes within PB leukocytes was determined by flow cytometry. The plasma and extracellular HMGB1 levels in unstimulated adherent cell (AC) cultures were measured using specific immunoassays. HMGB1 localization in ACs was assessed by immunofluorescent staining. The relative gene expression levels of tumor necrosis factor α (TNFα), interleukin-1 beta (IL-1<inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mi mathvariant="sans-serif">β</mi></semantics></math></inline-formula>) and HMGB1 were determined by quantitative polymerase chain reaction (qRT-PCR) in relation to the pain intensity (11-point VAS scores) in patients with LBP. The extracellular release of HMGB1 in the LBP patient AC cultures was significantly elevated (<i>p</i> = 0.001) and accompanied by its relocation into the cytoplasm from the nuclei. The number of CD14++ monocytes in the patients’ PB was significantly (<i>p</i> = 0.03) reduced, while the HMGB1 plasma levels remained comparable to those of the controls. The mRNA levels of TNFα, IL-1β and HMGB1 were overexpressed relative to the controls and those of HMGB1 and IL-1β were correlated with the VAS scores at a significant level (<i>p</i> = 0.01–0.03). The results suggest that HMGB1 may play an important role in the pathophysiology of chronic non-specific LBP.
first_indexed 2024-03-11T08:32:50Z
format Article
id doaj.art-ca2392ac548b4ccb9e0e6b3b0881eb8e
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-11T08:32:50Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-ca2392ac548b4ccb9e0e6b3b0881eb8e2023-11-16T21:41:40ZengMDPI AGLife2075-17292023-02-0113246810.3390/life13020468Clinical Biomarker of Sterile Inflammation, HMGB1, in Patients with Chronic Non-Specific Low Back Pain: A Pilot Cross-Sectional StudyJulita A. Teodorczyk-Injeyan0Heba Khella1H. Stephen Injeyan2Graduate Education and Research Programs, Canadian Memorial Chiropractic College, Toronto, ON M2H 3J1, CanadaDepartment of Clinical Education, Canadian Memorial Chiropractic College, Toronto, ON M2H 3J1, CanadaGraduate Education and Research Programs, Canadian Memorial Chiropractic College, Toronto, ON M2H 3J1, CanadaThe present study explores whether the inflammatory biomarker of sterile inflammation, high mobility box 1 (HMGB1), contributes to the inflammatory/nociceptive pathophysiology that characterizes chronic non-specific low back pain (LBP). Patients with chronic LBP (N = 10, >3 pain score on a 11-point Visual Analogue Scale, VAS) and asymptomatic participants (N = 12) provided peripheral blood (PB) samples. The proportion of classical CD14++ monocytes within PB leukocytes was determined by flow cytometry. The plasma and extracellular HMGB1 levels in unstimulated adherent cell (AC) cultures were measured using specific immunoassays. HMGB1 localization in ACs was assessed by immunofluorescent staining. The relative gene expression levels of tumor necrosis factor α (TNFα), interleukin-1 beta (IL-1<inline-formula><math xmlns="http://www.w3.org/1998/Math/MathML" display="inline"><semantics><mi mathvariant="sans-serif">β</mi></semantics></math></inline-formula>) and HMGB1 were determined by quantitative polymerase chain reaction (qRT-PCR) in relation to the pain intensity (11-point VAS scores) in patients with LBP. The extracellular release of HMGB1 in the LBP patient AC cultures was significantly elevated (<i>p</i> = 0.001) and accompanied by its relocation into the cytoplasm from the nuclei. The number of CD14++ monocytes in the patients’ PB was significantly (<i>p</i> = 0.03) reduced, while the HMGB1 plasma levels remained comparable to those of the controls. The mRNA levels of TNFα, IL-1β and HMGB1 were overexpressed relative to the controls and those of HMGB1 and IL-1β were correlated with the VAS scores at a significant level (<i>p</i> = 0.01–0.03). The results suggest that HMGB1 may play an important role in the pathophysiology of chronic non-specific LBP.https://www.mdpi.com/2075-1729/13/2/468HMGB1sterile inflammationlow back pain
spellingShingle Julita A. Teodorczyk-Injeyan
Heba Khella
H. Stephen Injeyan
Clinical Biomarker of Sterile Inflammation, HMGB1, in Patients with Chronic Non-Specific Low Back Pain: A Pilot Cross-Sectional Study
Life
HMGB1
sterile inflammation
low back pain
title Clinical Biomarker of Sterile Inflammation, HMGB1, in Patients with Chronic Non-Specific Low Back Pain: A Pilot Cross-Sectional Study
title_full Clinical Biomarker of Sterile Inflammation, HMGB1, in Patients with Chronic Non-Specific Low Back Pain: A Pilot Cross-Sectional Study
title_fullStr Clinical Biomarker of Sterile Inflammation, HMGB1, in Patients with Chronic Non-Specific Low Back Pain: A Pilot Cross-Sectional Study
title_full_unstemmed Clinical Biomarker of Sterile Inflammation, HMGB1, in Patients with Chronic Non-Specific Low Back Pain: A Pilot Cross-Sectional Study
title_short Clinical Biomarker of Sterile Inflammation, HMGB1, in Patients with Chronic Non-Specific Low Back Pain: A Pilot Cross-Sectional Study
title_sort clinical biomarker of sterile inflammation hmgb1 in patients with chronic non specific low back pain a pilot cross sectional study
topic HMGB1
sterile inflammation
low back pain
url https://www.mdpi.com/2075-1729/13/2/468
work_keys_str_mv AT julitaateodorczykinjeyan clinicalbiomarkerofsterileinflammationhmgb1inpatientswithchronicnonspecificlowbackpainapilotcrosssectionalstudy
AT hebakhella clinicalbiomarkerofsterileinflammationhmgb1inpatientswithchronicnonspecificlowbackpainapilotcrosssectionalstudy
AT hstepheninjeyan clinicalbiomarkerofsterileinflammationhmgb1inpatientswithchronicnonspecificlowbackpainapilotcrosssectionalstudy